Recurrent pregnancy loss is an important reproductive health issue, affecting 2%–5% of
couples. Common established causes include uterine anomalies, antiphospholipid …

Venous thromboembolism (VTE) is the third most common cause of death worldwide. The
incidence of VTE varies according to different countries, ranging from 1–2 per 1000 person …

Background This is the 2nd update to the 9th edition of these guidelines. We provide
recommendations on 17 PICO (Population, Intervention, Comparator, Outcome) questions …

2.1. 1. Epidemiology and burden of the disease. The annual incidence of first episode of
symptomatic DVT in the adult population ranges from 50 to 100 per 100 000 population, with …

Thrombophilia Testing and Venous Thrombosis | NEJM Skip to main content NEJM Group
Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to become a physician, build …

Background Hereditary and acquired thrombophilia are risk factors for venous
thromboembolism (VTE). Whether testing helps guide management decisions is …

Implantation is the first step in human reproduction. Successful implantation depends on the
crosstalk between embryo and endometrium. Recurrent implantation failure (RIF) is a …

Antiphospholipid syndrome (APS), an acquired autoimmune thrombophilia, is characterised
by thrombosis and/or pregnancy morbidity in association with persistent antiphospholipid …

Deep vein thrombosis: update on diagnosis and management Page 1 Narrative review MJA 2 10
(11) ▪ 17 June 2 0 19 Deep vein thrombosis: update on diagnosis and management Paul C …

Venous thromboembolism (VTE) is a preventable cause of postoperative morbidity and
mortality; however, audits suggest that the use of thromboprophylaxis is underused. In this …